White House Medical Unit Found to Have 'Severe and Systemic Problems' in Pharmacy Operations

A Department of Defense report reveals the unit dispensed prescription medications, including controlled substances, to ineligible staff under both Trump and Obama administrations.

The White House Medical Unit, under both the Trump and Obama administrations, has been found to have 'severe and systemic problems' with their pharmacy operations, according to a report by the U.S. Department of Defense.
The report revealed that the unit dispensed prescription medications, including controlled substances, to ineligible White House staff, violating federal law and regulation.
The investigation, which began in 2018, found that the unit also kept poor records and frequently made errors in medication counts.
Between 2017 and 2019, the unit spent nearly $150,000 on brand name medications instead of less expensive generic equivalents.
The Department of Defense report has called for the creation of stricter policies to prevent similar issues in the future.